Home › Funds › Citadel Advisors › IPHA
Citadel Advisors position in IPHA
INNATE PHARMA S A · Health Care
Latest position (Q2 2026)12.44K sh
Reported value held$22.89K
Portfolio Weight0.00%
First reportedQ2 2023
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2023 | 13.28K | $41.70K | New |
| Q2 2024 | 23.53K | $45.64K | New |
| Q3 2024 | 21.27K | $48.70K | Reduce |
| Q4 2024 | 11.85K | $21.93K | Reduce |
| Q1 2025 | 24.27K | $43.20K | Add |
| Q2 2025 | 26.62K | $46.58K | Add |
| Q3 2025 | 20.04K | $39.08K | Reduce |
| Q2 2026 | 12.44K | $22.89K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IPHA
- Morgan Stanley 43.52K sh · $80.08K · Q2 2026
- UBS Group AG 1.36K sh · $2.51K · Q2 2026